- Gevo, Inc. (NASDAQ: GEVO) Gets Big Boost Following Resumption of Isobutanol Production
- Will Generex Biotechnology Corp. (OTCQB: GNBT) Advance Breast Cancer Treatment to the Next Stage?
- Amicus Therapeutics, Inc. (NASDAQ: FOLD) Taking a Hit Following FDA Decision
- Titan Energy Worldwide, Inc. (OTCQB: TEWI) Generating Strong Revenue but can they become Profitable?
- Belo Corp. (NYSE: BLC) Soaring Following Announced Deal with Gannett Co., Inc. (NYSE: GCI)
OTC Equity Archives
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
Tagsaapl advertising alternative energy amex apple basic materials biopharmaceutical biotechnology cancer capital goods china copper drilling energy energy stocks exploration facebook fda fda approval gas gold gold mining google healthcare healthcare stocks investors ipad iphone medical marijuana mining NASDAQ natural gas nyse oil oil and gas otcbb penny stock penny stocks pharmaceutical Pink Sheets pinksheets s silver sprint stocks
OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.
Registration to our newsletter is FREE, Join today by entering your email below!
Tag Archives: cancer
Shares of Theragenics Corp. (NYSE: TGX) climbed to a 52-week high of 2.15 today after the medical device company serving the surgical products and prostate cancer treatment markets issued a press release announcing that they had received a takeover offer … Continue reading
Can Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) Advance Projects of Regen BioPharma to Clinical Trials?
The massive trading volume that Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) has attracted over the past few months has taken even greater heights on Monday as the biotechnology company focused on the development of regenerative medicine therapies and tools to … Continue reading
Will Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) Ease Investor Concern with Reported Progress of Subsidiary?
Few companies in the penny stock market have attracted the kind of attention that Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) has over the past week and on Friday that attention hit a new level with more than 121 million shares … Continue reading
Back on January 30, 2013 A.P. Pharma, Inc. (OTCBB: APPA) was trading at a 52-week high of 0.8870 due in large part to speculation that their lead product candidate for the prevention of chemotherapy-induced nausea, APF530, would manage to navigate … Continue reading
On Tuesday shares of MultiCell Technologies, Inc. (PINKSHEETS: MCET) opened at 0.0034, a nice jump from their previous close of 0.0020, but the day would offer even more surprises for shareholders as the biopharmaceutical company surged to a high of … Continue reading
For a company that hasn’t issued a press release since April 30, 2012 there has been a tremendous amount of interest in Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) as the biotechnology company has seen massive trading volume and Friday has … Continue reading
Can Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) Advance Cancer Drug into Phase III Trial Following Internal Review?
An internal review prompted by the discovery of vial coding discrepancies while preparing for an end of Phase II meeting with the FDA may have saved Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) as shares of the biopharmaceutical company that develops first-in-class … Continue reading
It is getting close to crunch time for A.P. Pharma, Inc. (OTCBB: APPA) as the specialty pharmaceutical company’s FDA assigned Prescription Drug User Fee Act (PDUFA) action date of March 27, 2013 is drawing near and the future of their … Continue reading
Can Inovio Pharmaceuticals, Inc. (AMEX: INO) Realize Potential with Multiple Synthetic Vaccines for Wide Range of Medical Issues?
After starting the month of November strong with a share price that hit 0.7200 Inovio Pharmaceuticals, Inc. (AMEX: INO) hit a snag and slipped as low as 0.4400 but the biotechnology company has been posting some pretty impressive numbers of … Continue reading
BSD Medical Corporation (NASDAQ: BSDM) Reports Significant Sales Spike but is it a Difference Maker?
BSD Medical Corporation (NASDAQ: BSDM) delivered some positive news on Tuesday, announcing that they had seen a 391% increase in sales for their MicroThermX Microwave Ablation System product line for September 2012, as compared to September 2011 with their disposable … Continue reading